Johnson & Johnson coronavirus vaccine could scale up to a billion doses by end of 2021: CEO
Published
Johnson & Johnson has narrowed down a lead coronavirus vaccine candidate to test on humans.
Full ArticlePublished
Johnson & Johnson has narrowed down a lead coronavirus vaccine candidate to test on humans.
Full Article